To test for these interactions, we conducted a case control study to (i) identify the gene-environment interactions of IGF-1 rs1520220, IGFBP-3 rs2854744, BMI, and soy isoflavone intake on BC risk; and (ii) estimate the effects of gene-environment interactions. This evidence concerns the gene IGFBP3 and breast cancer.